USP<797> Overview

Approved For SNMMI-TS Voice Credit

Overview: This course educates the nuclear medicine community about USP <797> and how it impacts our nuclear pharmacy and nuclear medicine practices including compounding risk levels stated by USP<797> and how they apply to radiopharmaceuticals, ISO class descriptions, and quality and safety requirements for garbing and sterile compounding.

Note: If you need the registration code for this course, contact your local Jubilant Radiopharma Radiopharmacies Division representative or email

SNMMI-TS VOICE Reference Number: CEC01782
Approved for 1.0 CEH(s) Category A  [California Scope: R]